Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule (Q37445501)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on May 2009

Language	Label	Description	Also known as
English	Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule	scientific article published on May 2009

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

1 reference

Europe PubMed Central

Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

0 references

Orthoebolavirus zairense

0 references

Barney S. Graham

3

object named as

Barney S Graham

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

1

object named as

Nancy J Sullivan

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

author name string

Julie E Martin

2

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Gary J Nabel

4

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

language of work or name

0 references

publication date

1 May 2009

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Nature Reviews Microbiology

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

393-400

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Ebolavirus and Marburgvirus: insight the Filoviridae family

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2129

31 March 2020

Vaccines: correlates of vaccine-induced immunity

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2129

31 March 2020

A framework for assessing immunological correlates of protection in vaccine trials

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2129

31 March 2020

Correlates, surrogates, and vaccines.

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2129

31 March 2020

Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2129

31 March 2020

Inflammatory responses in Ebola virus-infected patients.

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2129

31 March 2020

Prevalence of IgG antibodies to Ebola virus in individuals during an Ebola outbreak, Democratic Republic of the Congo, 1995.

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2129

31 March 2020

Cytokine and chemokine expression in humans infected with Sudan Ebola virus

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2129

31 March 2020

Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995.

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2129

31 March 2020

Human asymptomatic Ebola infection and strong inflammatory response

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2129

31 March 2020

Early immune responses accompanying human asymptomatic Ebola infections

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2129

31 March 2020

Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2129

31 March 2020

Sequence-based human leukocyte antigen-B typing of patients infected with Ebola virus in Uganda in 2000: identification of alleles associated with fatal and nonfatal disease outcomes

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2129

31 March 2020

Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2129

31 March 2020

Disease modeling for Ebola and Marburg viruses

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2129

31 March 2020

Immunization for Ebola virus infection

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2129

31 March 2020

The assembly of Ebola virus nucleocapsid requires virion-associated proteins 35 and 24 and posttranslational modification of nucleoprotein

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2129

31 March 2020

Effect of Ebola virus proteins GP, NP and VP35 on VP40 VLP morphology

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2129

31 March 2020

Contribution of ebola virus glycoprotein, nucleoprotein, and VP24 to budding of VP40 virus-like particles

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2129

31 March 2020

Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2129

31 March 2020

Protection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral nucleoprotein

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2129

31 March 2020

Epitopes involved in antibody-mediated protection from Ebola virus

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2129

31 March 2020

Passive transfer of antibodies protects immunocompetent and imunodeficient mice against lethal Ebola virus infection without complete inhibition of viral replication.

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2129

31 March 2020

Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2129

31 March 2020

Persistent infection with ebola virus under conditions of partial immunity

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2129

31 March 2020

CD8-mediated protection against Ebola virus infection is perforin dependent

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2129

31 March 2020

Induction of humoral and CD8+ T cell responses are required for protection against lethal Ebola virus infection

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2129

31 March 2020

Role of natural killer cells in innate protection against lethal ebola virus infection

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2129

31 March 2020

Development of a preventive vaccine for Ebola virus infection in primates

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2129

31 March 2020

Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2129

31 March 2020

Successful topical respiratory tract immunization of primates against Ebola virus

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2129

31 March 2020

Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2129

31 March 2020

Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2129

31 March 2020

Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2129

31 March 2020

Characterization of functional and phenotypic changes in anti-Gag vaccine-induced T cell responses and their role in protection after HIV-1 infection

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2129

31 March 2020

Development and homeostasis of T cell memory in rhesus macaque

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2129

31 March 2020

A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2129

31 March 2020

Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2129

31 March 2020

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2129

31 March 2020

Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates.

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2129

31 March 2020

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2129

31 March 2020

Vaccine To Confer to Nonhuman Primates Complete Protection against Multistrain Ebola and Marburg Virus Infections

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2129

31 March 2020

Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses

1 reference

https://pubmed.ncbi.nlm.nih.gov/19369954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New drug and biological drug products; evidence needed to demonstrate effectiveness of new drugs when human efficacy studies are not ethical or feasible. Final rule.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19369954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/NRMICRO2129

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37445501&oldid=2200376552"